RNR NYSE Reinsurance Financials FY2016βFY2025
RenaissanceRe had $12.8B of revenue in fiscal 2025, up 9.9% on the year before. Over five years, revenue changed +20.0% a year on average.
Hi! I read RenaissanceReβs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
+9.9%
Yes. Sales grew 9.9% last year.
Does it make a profit?
20.9%
Yes. It keeps 20.9% of every sale as profit.
Is debt under control?
Net cash
Yes. It has more cash than debt.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days RenaissanceRe did it, and the next one. Share prices often move a lot on those days.
Next results
October 27, 2026
Tuesday Β· tomorrow
| Date | Results for | Time | Source |
|---|---|---|---|
| Jul 22, 2026 | Q2 '26 | After the market closes | 8-K β |
| Apr 28, 2026 | Q1 '26 | After the market closes | 8-K β |
| Feb 3, 2026 | Q4 '25 | After the market closes | 8-K β |
| Oct 28, 2025 | Q3 '25 | After the market closes | 8-K β |
| Jul 23, 2025 | Q2 '25 | After the market closes | 8-K β |
| Apr 23, 2025 | Q1 '25 | After the market closes | 8-K β |
| Jan 28, 2025 | Q4 '24 | After the market closes | 8-K β |
| Nov 6, 2024 | Q3 '24 | After the market closes | 8-K β |
From SEC filings: the results press release (8-K) or, without one, the quarterly or annual report.
KIRA Β· RenaissanceRe had $12.8B of revenue in fiscal 2025, up 9.9% on the year before. Over five years, revenue changed +20.0% a year on average.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· RenaissanceRe made $2.7B of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew 19.3% a year.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
KIRA Β· RenaissanceRe returned $1.7B to shareholders in fiscal 2025. The diluted share count fell 9.5%.
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· In the last 12 months, insiders sold $16.2M of shares on the open market and bought none.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$16.2M
3 insiders
Of sales under plans
78%
$12.6M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | Ross CurtisEVP,Chief Portfolio Officer | Sold plan | 9,623 | $337.60 | $3.2M | Form 4 |
| Aug 26, 2026 | Ross CurtisEVP,Chief Portfolio Officer | Sold plan | 377 | $335.00 | $0.1M | Form 4 |
| Aug 24, 2026 | Ross CurtisEVP,Chief Portfolio Officer | Sold plan | 5,000 | $330.00 | $1.7M | Form 4 |
| Aug 17, 2026 | Ross CurtisEVP,Chief Portfolio Officer | Sold plan | 5,000 | $325.00 | $1.6M | Form 4 |
| Jul 28, 2026 | Robert QutubEVP, Chief Financial Officer | Sold | 5,000 | $333.03 | $1.7M | Form 4 |
| May 18, 2026 | Carol P SandersDirector | Sold | 1,479 | $297.36 | $0.4M | Form 4 |
| Feb 6, 2026 | Robert QutubEVP, Chief Financial Officer | Sold | 5,000 | $305.75 | $1.5M | Form 4 |
| Feb 5, 2026 | Ross CurtisEVP,Chief Portfolio Officer | Sold plan | 5,000 | $305.00 | $1.5M | Form 4 |
| Feb 4, 2026 | Ross CurtisEVP,Chief Portfolio Officer | Sold plan | 15,000 | $295.00 | $4.4M | Form 4 |
Can it carry its debts, and how well does it use its money?
KIRA Β· RenaissanceRe has $4.1B more cash than debt.
Cash, debt and the ratios that show how comfortably RenaissanceRe can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $7.2B | $5.9B | $6.5B | $6.2B | $6.5B |
| Debt incl. finance leases | $1.2B | $1.2B | $2.0B | $1.9B | $2.3B |
| Net debt / EBITDA | β | β | β1.5x | β1.3x | β1.0x |
| Debt / equity | 0.2x | 0.2x | 0.2x | 0.2x | 0.2x |
| Interest coverage | β1.4x | β24.2x | 43.5x | 32.9x | 34.2x |
| Total assets | $34.0B | $36.6B | $49.0B | $50.7B | $53.8B |
| Total liabilities | $23.8B | $26.7B | $33.5B | $33.2B | $34.6B |
| Shareholders' equity | $6.6B | $5.3B | $9.5B | $10.6B | $11.6B |
| Net debt (β = net cash) | β$6.0B | β$4.7B | β$4.5B | β$4.3B | β$4.1B |
KIRA Β· Its return on capital was 54.2%: every 100 invested in the business earned about 54 in a year.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | 1.5% | β4.6% | β1.9% |
| Altman Z'' | β | β | β |
What does the share cost, and how does it compare?
KIRA Β· At $352.60 a share, the company is worth $14.6B.
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
In plain words: Move the sliders to try your own guesses about growth. The result is what one share would be worth if those guesses came true. Different guesses give very different answers.
Value per share
β
Adds net cash of $4.1B and divides by 46.5M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Value per share
β
Reference multiples: today 6.3x Β· peers 10.3x Β· sector 13.7x.
KIRA Β· RenaissanceRe grew sales faster than 4 of its 4 similar companies.
Each companyβs latest fiscal year. Fiscal years end in different months, so periods donβt line up exactly.
In plain words: The same numbers for similar companies, so you can tell whether a figure is high or low for this kind of business.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| RenaissanceRe RNR | $14.6B | 9.9% | β | β | 54.2% | β | β | |
| Everest Group EG | $15.5B | 1.2% | β | β | β | 8.4x | β | Compare β |
| Reinsurance Group of America RGA | $17.4B | 7.2% | β | β | β | 11.6x | β | Compare β |
| MGIC Investment MTG | $6.1B | 0.5% | β | 70.2% | β | 9.0x | β | Compare β |
| Assurant AIZ | $14.2B | 7.9% | β | 12.5% | 17.5% | 13.6x | β | Compare β |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.7B | $2.1B | $2.1B | $4.2B | $5.2B | $5.3B | $5.1B | $9.1B | $11.7B | $12.8B |
| Interest expense | $42.1M | $44.2M | $47.1M | $58.4M | $50.5M | $47.5M | $48.3M | $73.2M | $93.8M | $121M |
| Pretax income | $630M | β$328M | $263M | $968M | $996M | β$114M | β$1.2B | $3.1B | $3.0B | $4.0B |
| Income tax | $0.3M | $26.5M | β$6.3M | $17.2M | $2.9M | β$10.7M | β$59.0M | β$510M | $32.6M | $396M |
| Net income | $503M | β$222M | $227M | $749M | $762M | β$40.2M | β$1.1B | $2.6B | $1.9B | $2.7B |
| Diluted EPS | $11.43 | β$6.15 | $4.91 | $16.29 | $15.31 | β$1.57 | β$25.50 | $52.27 | $35.21 | $56.03 |
| Diluted shares | 0.04B | 0.04B | 0.04B | 0.04B | 0.05B | 0.05B | 0.04B | 0.05B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $485M | $1.0B | $1.2B | $2.1B | $2.0B | $1.2B | $1.6B | $1.9B | $4.2B | $3.7B |
| Depreciation and amortization | $29.3M | $31.2M | $0.1M | β$59.0M | $16.7M | β$21.0M | β$26.9M | β$135M | $259M | β$14.1M |
| Stock-based compensation | $47.4M | $37.2M | $35.7M | $41.4M | $43.7M | $40.0M | $45.2M | $60.3M | $71.4M | $77.5M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $276M | $0.0M | $0.0M | $0.0M | $2.4B | $0.0M | $0.0M |
| Share buybacks | $309M | $189M | $0.0M | $0.0M | $62.6M | $1.0B | $167M | $0.0M | $667M | $1.6B |
| Dividends paid | $51.6M | $51.4M | $52.8M | $59.4M | $68.5M | $67.8M | $64.7M | $75.1M | $80.8M | $74.8M |
| Dividends and buybacks | $361M | $240M | $52.8M | $59.4M | $131M | $1.1B | $231M | $75.1M | $748M | $1.7B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $1.8B | $2.4B | $3.7B | $5.9B | $6.7B | $7.2B | $5.9B | $6.5B | $6.2B | $6.5B |
| Total debt | $949M | $990M | $991M | $1.4B | $1.1B | $1.2B | $1.2B | $2.0B | $1.9B | $2.3B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $22.5M | $22.0M | $21.5M | $21.0M | $20.4M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Total assets | $12.4B | $15.2B | $18.7B | $26.3B | $30.8B | $34.0B | $36.6B | $49.0B | $50.7B | $53.8B |
| Total liabilities | $6.3B | $9.5B | $11.6B | $17.3B | $19.9B | $23.8B | $26.7B | $33.5B | $33.2B | $34.6B |
| Shareholders' equity | $4.9B | $4.4B | $5.0B | $6.0B | $7.6B | $6.6B | $5.3B | $9.5B | $10.6B | $11.6B |
| Margins | ||||||||||
| EBITDA margin | 40.6% | β12.0% | 14.9% | 23.0% | 20.6% | β1.7% | β23.7% | 33.4% | 28.6% | 32.1% |
| Net margin | 29.1% | β10.6% | 11.0% | 17.8% | 14.7% | β0.8% | β21.0% | 28.0% | 16.0% | 20.9% |
| Returns | ||||||||||
| Return on capital | 16.8% | β6.4% | 11.5% | β | β | β | β | β | 54.4% | 54.2% |
| Return on equity | 10.5% | β4.8% | 4.8% | 13.6% | 11.3% | β0.6% | β17.8% | 34.7% | 18.7% | 24.2% |
| Return on assets | 4.2% | β1.6% | 1.3% | 3.3% | 2.7% | β0.1% | β3.0% | 6.0% | 3.8% | 5.1% |
| Growth | ||||||||||
| Revenue growth | 14.0% | 21.8% | β1.4% | 102.5% | 23.1% | 2.0% | β4.1% | 80.5% | 28.0% | 9.9% |
| Net income growth | 16.6% | β144.2% | β | 229.3% | 1.8% | β105.3% | β | β | β27.0% | 43.4% |
| EPS growth | 23.2% | β153.8% | β | 231.8% | β6.0% | β110.3% | β | β | β32.6% | 59.1% |
| Share count change | β4.5% | β4.1% | β0.3% | 8.6% | 9.3% | β0.0% | β8.8% | 10.6% | 7.8% | β9.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | β1.2x | β | β8.7x | β4.7x | β5.3x | β | β | β1.5x | β1.3x | β1.0x |
| Debt / equity | 0.2x | 0.2x | 0.2x | 0.2x | 0.2x | 0.2x | 0.2x | 0.2x | 0.2x | 0.2x |
| Interest coverage | 16.0x | β6.4x | 6.6x | 17.6x | 20.7x | β1.4x | β24.2x | 43.5x | 32.9x | 34.2x |
| Capital allocation | ||||||||||
| Stock comp / revenue | 2.7% | 1.8% | 1.7% | 1.0% | 0.8% | 0.8% | 0.9% | 0.7% | 0.6% | 0.6% |
| Quality scores | ||||||||||
| Accruals ratio | 0.2% | β9.1% | β5.9% | β6.2% | β4.3% | β3.9% | β7.6% | 1.5% | β4.6% | β1.9% |
Source: SEC EDGAR XBRL filings (CIK 0000913144). Data updated October 18, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
